RESEARCH LETTER

Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study

糖尿病合并新型冠状病毒性肺炎(COVID-19)患者入院一周内的血糖升高与重症进展有关:一个多中心观察研究

Ping Ling

orcid.org/0000-0002-9889-5812

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China

Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China

Search for more papers by this author

Sihui Luo,

Sihui Luo

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China

Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China

Search for more papers by this author

Xueying Zheng,

Xueying Zheng

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China

Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China

Search for more papers by this author

Guoqi Cai,

Guoqi Cai

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China

Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China

Search for more papers by this author

Jianping Weng,

Corresponding Author

Jianping Weng

[email protected]

orcid.org/0000-0002-7889-1697

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China

Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China

Correspondence

Jianping Weng, Division of Life Sciences and Medicine, University of Science and Technology of China, 97 Jinzhai Road, Hefei, Anhui 230026, China.

Email: [email protected]

Search for more papers by this author

Ping Ling,

Ping Ling

orcid.org/0000-0002-9889-5812

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China

Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China

Search for more papers by this author

Sihui Luo,

Sihui Luo

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China

Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China

Search for more papers by this author

Xueying Zheng,

Xueying Zheng

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China

Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China

Search for more papers by this author

Guoqi Cai,

Guoqi Cai

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China

Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China

Search for more papers by this author

Jianping Weng,

Corresponding Author

Jianping Weng

[email protected]

orcid.org/0000-0002-7889-1697

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China

Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China

Correspondence

Jianping Weng, Division of Life Sciences and Medicine, University of Science and Technology of China, 97 Jinzhai Road, Hefei, Anhui 230026, China.

Email: [email protected]

Search for more papers by this author

First published: 11 October 2020

https://doi.org/10.1111/1753-0407.13121

Citations: 12

Ping Ling and Sihui Luo contributed equally to this work.

Funding information: Fundamental Research Funds for the Central Universities, Grant/Award Numbers: YD9110002002, YD9110002008, YD9110004001

Share a link

Email
Wechat
Bluesky

Graphical Abstract

Highlights

Fasting blood glucose < 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes.
Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes.
Mean blood glucose seemed not to be associated with poor prognosis of COVID-19.

REFERENCES

1Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239-1242.
10.1001/jama.2020.2648
CAS PubMed Web of Science® Google Scholar
2Williamson EJ, Walker AJ, Bhaskaran K, et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients. Nature. 2020; 584: 430-436. https://doi.org/10.1038/s41586-020-2521-4.
10.1038/s41586-020-2521-4
CAS PubMed Web of Science® Google Scholar
3Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;e3319. https://doi.org/10.1002/dmrr.3319.
10.1002/dmrr.3319
PubMed Web of Science® Google Scholar
4Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. 2020; 16(6): 297-298.
10.1038/s41574-020-0353-9
CAS PubMed Web of Science® Google Scholar
5Zhu L, She ZG, Cheng X, et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020; 31: 1068-1077.e1063.
10.1016/j.cmet.2020.04.021
CAS PubMed Web of Science® Google Scholar
6Smith SM, Boppana A, Traupman JA, et al. Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19. J Med Virol. 2020; 1-7. https://doi.org/10.1002/jmv.26227.
PubMed Web of Science® Google Scholar
7 Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia released by the National Health Commission of the People's Republic of China. http://www.nhc.gov.cn.
Google Scholar
8Sardu C, D'Onofrio N, Balestrieri ML, et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? Diabetes Care. 2020; 43: 1408-1415.
10.2337/dc20-0723
CAS PubMed Web of Science® Google Scholar
9Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract. 2020; 164:108214.
10.1016/j.diabres.2020.108214
CAS PubMed Web of Science® Google Scholar
10Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020; 63(8): 1500-1515.
10.1007/s00125-020-05180-x
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume13, Issue1

January 2021

Pages 89-93

This article also appears in:

COVID-19 and Diabetes Management

Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study

糖尿病合并新型冠状病毒性肺炎(COVID-19)患者入院一周内的血糖升高与重症进展有关:一个多中心观察研究

Graphical Abstract

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study

糖尿病合并新型冠状病毒性肺炎(COVID-19)患者入院一周内的血糖升高与重症进展有关:一个多中心观察研究

Graphical Abstract

REFERENCES

Citing Literature

References

Related

Information